World & BusinessPfizer India stresses patient safety after Karnataka FDA crackdown
The Economic Times reports that Karnataka’s FDA canceled 16 drug licenses and suspended eight others over counterfeit drugs. Pfizer has removed affected batches from the market, the outlet says.
TLDR
The Economic Times reports that a raid uncovered an illegal operation repacking low-cost medicines as branded drugs, particularly Pfizer products. Karnataka’s FDA canceled 16 drug licenses and suspended eight others over counterfeit drugs. The outlet says Pfizer removed affected batches from the market and is cooperating with authorities. Following the crackdown, Pfizer India said patient safety and product quality were its top priorities.
Pfizer India stresses patient safety after Karnataka FDA crackdown
The Economic Times reports that Karnataka’s FDA canceled 16 drug licenses and suspended eight others over counterfeit drugs. Pfizer has removed affected batches from the market, the outlet says.
TLDR
The Economic Times reports that a raid uncovered an illegal operation repacking low-cost medicines as branded drugs, particularly Pfizer products. Karnataka’s FDA canceled 16 drug licenses and suspended eight others over counterfeit drugs. The outlet says Pfizer removed affected batches from the market and is cooperating with authorities. Following the crackdown, Pfizer India said patient safety and product quality were its top priorities.